文献速递心力衰竭与心肌病

肥厚型心肌病:概念演变与诊疗进展

Changing concepts in heart muscle disease: the evolving understanding of hypertrophic cardiomyopathy.
PubMed 文献 · Heart · 2022-01-01

影像学进步、人工智能应用及筛查效率提升促进了精准及时诊断,分子遗传学转化与新型疗法随机试验正在拓展治疗前景。

要点

  • HCM现被认为相对常见,可贯穿全生命周期发病,表型异质。
  • 影像学进步、人工智能及筛查优化助力更精准及时的诊断。
  • 多数 contemporary 诊断患者可预期正常寿命及良好功能状态与生活质量。

核心结论

  • HCM已从罕见致死性年轻成人疾病转变为相对常见、多数可有效管理的异质性疾病。
  • 早期诊断能力提升与治疗创新结合,使多数当代诊断患者可预期正常寿命和良好生活质量。

主要发现

  • 如今HCM被认识为贯穿全生命周期、临床表型异质、多数个体可有效管理的相对常见疾病。
  • 对疾病认识提高、医生诊断意愿增强、心脏影像进步(含更多人工智能应用)及筛查效率提升共同促进了更精准及时的诊断。
  • 分子遗传学从基础到临床转化增加,针对改善或可能预防疾病的新型疗法随机临床试验增多。

临床怎么用

  • 提高对HCM的认识并减少诊断犹豫,结合心脏影像(含人工智能)和筛查优化实现精准及时诊断。
  • 对当代诊断的HCM患者,多数可预期正常寿命、良好功能状态和生活质量。
  • 关注分子遗传学转化及新型疗法临床试验进展,为患者提供更多治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sixty years ago, hypertrophic cardiomyopathy (HCM) was considered a rare lethal disease that affected predominantly young adults and for which there were few treatment options. Today, it is recognised to be a relatively common disorder that presents throughout the life course with a heterogeneous clinical phenotype that can be managed effectively in the majority of individuals. A greater awareness of the condition and less reluctance from healthcare practitioners to make the diagnosis, coupled with improvements in cardiac imaging, including greater use of artificial intelligence and improved yields from screening efforts, have all helped facilitate a more precise and timely diagnosis. This enhanced ability to diagnose HCM early is being paired with innovations in treatment, which means that the majority of patients receiving a contemporary diagnosis of HCM can anticipate a normal life expectancy and expect to maintain a good functional status and quality of life. Indeed, with increasing translation of molecular genetics from bench to bedside associated with a growing number of randomised clinical trials of novel therapies aimed at ameliorating or perhaps even preventing the disease, the next chapter in the story for HCM will provide much excitement and more importantly, offer much anticipated reward for our patients.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Moody WE, Elliott PM. Changing concepts in heart muscle disease: the evolving understanding of hypertrophic cardiomyopathy. Heart. 2022. PMID: 35459726. doi:10.1136/heartjnl-2021-320145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。